Brainsgate

medical devices

About

BrainsGate is an Israeli medical device company founded in 2000, specializing in innovative electrical stimulation treatments targeting the Sphenopalatine Ganglion (SPG). The company focuses on developing implantable devices that modulate the brain-blood barrier and enhance cerebral blood flow, particularly for treating ischemic stroke. Their flagship product is an implantable device designed to stimulate the SPG, which may aid in stroke recovery by promoting neurological repair. BrainsGate's clinical development has included studies reviewed by regulatory bodies, including the U.S. Food and Drug Administration (FDA). The company primarily serves healthcare providers and institutions specializing in stroke treatment and neurological care, as well as researchers interested in neurostimulation therapies. Recognized as a pioneer in the medical technology sector, BrainsGate is committed to advancing neurostimulation for stroke recovery and addressing cerebrovascular diseases through innovative therapeutic approaches.

Technologies

Salesforce Cloudflare DNS Outlook Microsoft Office 365 AddThis Mobile Friendly Google Analytics Nginx JW Player reCAPTCHA

Keywords

neurostimulation stroke vascular dementia medical equipment manufacturing medical devices medical equipment and supplies manufacturing cns disease therapy neurovascular intervention medical technology implant at roof of mouth blood flow increase neurostimulation implant clinical trial design neuroscience research electrode technology neurovascular therapy blood flow augmentation device regulatory compliance minimally invasive device neurotechnology development cerebral blood flow stroke treatment neurostimulation technology minimally invasive procedure medical device innovation innovative therapies electrical nerve stimulation acute ischemic stroke healthcare clinical research

Location

4 Rotem HaMidbar Street, Caesarea, Haifa District, Israel

Related Companies

Companies in the same industry